Novel case of androgen receptor‐positive cancer of unknown primary without serum prostate‐specific antigen elevation that became progression free in the long term after primary combined androgen blockade

INTRODUCTION: The prognosis of cancer of unknown primary is very poor. Such a prognosis can be improved by characterizing primary characteristics and developing tailored site‐specific therapy, especially for androgen receptor‐positive adenocarcinoma. However, in such cases without elevated prostate‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuyama, Nayuka, Naiki, Taku, Naiki‐Ito, Aya, Chaya, Ryosuke, Kawai, Tatsuya, Etani, Toshiki, Nagai, Takashi, Kato, Hiroyuki, Kubota, Yasue, Yasui, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784734/
https://www.ncbi.nlm.nih.gov/pubmed/33426501
http://dx.doi.org/10.1002/iju5.12241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784734/
https://www.ncbi.nlm.nih.gov/pubmed/33426501
http://dx.doi.org/10.1002/iju5.12241

Ejemplares similares